Treatment of brain metastases from HER-2-positive breast cancer: current status and new concepts

Author： Bartolotti Marco   Franceschi Enrico   Brandes Alba A  

Publisher： Future Medicine

ISSN： 1479-6694

Source： Future Oncology, Vol.9, Iss.11, 2013-11, pp. : 1653-1664

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

HER2-Positive Breast Cancer: Current Treatment Strategies

By Perez Edith   Baweja Mansoina  

Cancer Investigation, Vol. 26, Iss. 6, 2008-07 ,pp. : 545-552

Informa Healthcare

Access to resources Recommend Favorite

HER2-positive Breast Cancer Brain Metastases: Multiple Responses to Systemic Chemotherapy and Trastuzumab—a Case Report

By Church D.   Bahl A.   Jones A.   Price C.  

Journal of Neuro-Oncology, Vol. 79, Iss. 3, 2006-09 ,pp. : 289-292

Springer Publishing Company

Access to resources Recommend Favorite

Occult brain metastases in HER2-positive breast cancer patients: Frequency and response to radiotherapy

By Niwinska Anna   Tacikowska Małgorzata   Pienkowski Tadeusz  

Acta Oncologica, Vol. 46, Iss. 7, 2007-01 ,pp. : 1027-1029

Informa Healthcare

Access to resources Recommend Favorite

Treatment strategy for HER2-positive breast cancer

By Mukai Hirofumi  

International Journal of Clinical Oncology, Vol. 15, Iss. 4, 2010-08 ,pp. : 335-340

Springer Publishing Company

Access to resources Recommend Favorite

PI3K pathway inhibitors for the treatment of brain metastases with a focus on HER2+ breast cancer

By Peddi Parvin   Hurvitz Sara  

Journal of Neuro-Oncology, Vol. 117, Iss. 1, 2014-03 ,pp. : 7-13

Springer Publishing Company

Access to resources Recommend Favorite